Our data indicate that inhibition of integrin α5β1 ameliorates VEGF-induced retinal detachment by suppressing NLRP3 inflammasome signaling in Tet/opsin/VEGF transgenic mice, which could be beneficial for the treatment of RNV diseases. The gene discussed is VEGFA; the disease is retinal detachment.